CLINUVEL Delivers Record Revenues and Profit
Melbourne, Australia, 26 August 2021 ASX: XETRA-DAX: NASDAQ INTERNATIONAL DESIGNATION: CUV UR9...
Read MoreDividend/Distribution - CUV
Melbourne, Australia, 26 August 2021 ASX: XETRA-DAX: NASDAQ INTERNATIONAL DESIGNATION: CUV UR9...
Read MoreInsider Insights III: Willem Blijdorp - Challenges & the Future
CLINUVEL today launches the third and final part of the Insider Insights...
Read MoreInsider Insights II: Willem Blijdorp - CLINUVEL’s Products, People & Social Purpose
CLINUVEL today launches the next part of the Insider Insights series, featuring...
Read MoreInsider Insights: Willem Blijdorp - Chair of The CLINUVEL Group
CLINUVEL today launched the Insider Insights series, featuring Chair Willem Blijdorp on...
Read MoreCLINUVEL Presentation to Jefferies Healthcare Conference
Melbourne, Australia, 04 June 2021 ASX: XETRA-DAX: NASDAQ INTERNATIONAL DESIGNATION: CUV UR9...
Read MoreWilsons Initiates Research Coverage of CLINUVEL
Melbourne, Australia, 26 April 2021 ASX: XETRA-DAX: NASDAQ INTERNATIONAL DESIGNATION: CUV UR9...
Read MoreCLINUVEL Strategic Update II
Melbourne, Australia, 12 April 2021 CLINUVEL today announced its second Strategic Update,...
Read MoreMedia Release - CLINUVEL Expands DNA Repair Program
SCENESSE® (afamelanotide 16mg) to be evaluated in xeroderma pigmentosum variant (XP-V) CLINUVEL...
Read MoreSCENESSE® To Be Evaluated in Xeroderma Pigmentosum Variant (XPV)
CLINUVEL today announced that it has reached agreement with clinical and academic...
Read MoreSCENESSE® Granted Market Access In Israel
CLINUVEL today announced that SCENESSE® (afamelanotide 16mg) has been added to the...
Read MoreH.C. Wainwright Bioconnect Conference 2021
12 January 2021 https://vimeo.com/clinuvel/review/499638631/b90c97ddb9 Download Presentation & Speaker Notes
Read MoreAppendix 3G
Notification of issue, conversion or payment up of equity & securities. Download...
Read MoreSCENESSE® DNA REPAIR STUDY IN HEALTHY VOLUNTEERS APPROVED
Melbourne, Australia, 30 November 2020 CLINUVEL PHARMACEUTICALS LTD today announced that it...
Read MoreJefferies Virtual London Healthcare Conference Presentation
20 November 2020 Download presentation & speaker’s notes
Read More